Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IceCure Medical (ICCM) Cost of Revenue (2020 - 2025)

Historic Cost of Revenue for IceCure Medical (ICCM) over the last 6 years, with Q3 2025 value amounting to $573000.0.

  • IceCure Medical's Cost of Revenue rose 3419.2% to $573000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 657.64%. This contributed to the annual value of $1.8 million for FY2024, which is 461.38% down from last year.
  • Per IceCure Medical's latest filing, its Cost of Revenue stood at $573000.0 for Q3 2025, which was up 3419.2% from $394000.0 recorded in Q2 2025.
  • In the past 5 years, IceCure Medical's Cost of Revenue ranged from a high of $2.0 million in Q4 2022 and a low of $313000.0 during Q1 2022
  • In the last 5 years, IceCure Medical's Cost of Revenue had a median value of $468000.0 in 2022 and averaged $546842.1.
  • Its Cost of Revenue has fluctuated over the past 5 years, first soared by 17557.35% in 2022, then plummeted by 6640.55% in 2023.
  • Quarter analysis of 5 years shows IceCure Medical's Cost of Revenue stood at $741000.0 in 2021, then skyrocketed by 175.57% to $2.0 million in 2022, then tumbled by 66.41% to $686000.0 in 2023, then crashed by 33.24% to $458000.0 in 2024, then rose by 25.11% to $573000.0 in 2025.
  • Its last three reported values are $573000.0 in Q3 2025, $394000.0 for Q2 2025, and $507000.0 during Q1 2025.